TheraSphere™ Y-90 Glass Microspheres: PMA and LEGACY
Vložit
- čas přidán 27. 06. 2021
- Hear from key thought leaders on what the recent LEGACY study and PMA approval means for TheraSphere™ Y-90 Glass Microspheres; the first and only medical device approved by the FDA for the treatment of HCC liver cancer.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
PI-1055805-AB - Věda a technologie
